|
Oct. 2, 2025
| This week’s procurement news and insights for supply chain leaders
|
NOTE FROM THE EDITOR
Tariffs on furniture and wood imports are slated to start in just a couple of weeks — the latest move in the Trump administration’s push to reshape U.S. trade policy.
Here are the duty rates the president will implement per an executive order signed on Monday:
- Softwood timber and lumber imports: 10%
- Upholstered wooden products (couches, sofas, chairs, etc.): 25%
- Kitchen cabinets, vanities and parts used in manufacturing those goods: 25%
For more details on the order, including exceptions and planned rate hikes on certain products, check out our top story!
See you next week,
|
|
Kelly Stroh
Editor, Supply Chain Dive
Email
|
An executive order from President Donald Trump installs a 25% tariff on couch, sofa, chair and kitchen cabinet imports and a 10% duty on timber and lumber.
|
“The impacts of higher tariff rates are yet to be fully felt in the US economy,” according to a report from OECD, a global policy forum.
|
Potential impacts will largely depend on whether the policy affects truck parts and the U.S.-Mexico-Canada Agreement.
|
In this on-demand webinar, viewers will learn how the latest generation of cloud-based ERP can help mid-market CPG operations achieve resilience:
|
Next year’s trade shows will showcase resilience strategies, technology adoption and talent development as companies contend with tariff volatility and other challenges.
|
The company reported the partial closure of a production facility as part of its Transform and Modernize initiative.
|
The pharmaceutical giant is also planning a $5 billion manufacturing site in Virginia, with two more U.S. facilities expected to be announced later this year.
|
The KFC and Taco Bell franchisor is consolidating separate supply chains for its portfolio of restaurants to improve supplier relationships.
|
Scott Fremont started as chief supply chain officer for the grocery chain earlier this month following nearly 18 years with Target.
|
What We’re Reading
BioPharma Dive
|
| 
